休斯顿大学验光研究人员警告不要使用低强度红光疗法。 University of Houston optometry researcher warns against using low-level red light therapy.

休斯顿大学验光研究人员警告不要使用低强度红光 (LLRL) 疗法来控制近视，尤其是儿童近视，因为可能会损伤视网膜。 A University of Houston optometry researcher has warned against using low-level red light (LLRL) therapy to control myopia, particularly in children, due to potential retinal injury. 尽管据报道 LLRL 疗法可有效减少近视进展，但由于其安全性尚未得到充分研究，因此 LLRL 疗法可能会对视网膜造成光化学和热损伤的风险。 Despite its reported effectiveness in reducing myopia progression, LLRL therapy may pose risks of photochemical and thermal damage to the retina, as its safety profile has not been fully investigated. 使用该疗法的儿童被要求每天两次观察红色发光仪器三分钟，这可能会超出安全限度。 Children using the therapy are instructed to look into a red light-emitting instrument for three minutes, twice a day, which may exceed safety limits. 研究人员发现，所评估的两种 LLRL 设备都超过了最大允许曝光的亮度剂量，使视网膜面临光化学损伤的风险。 The researcher found that both LLRL devices evaluated exceeded the luminance dose maximum permissible exposure, putting the retina at risk of photochemical damage.